Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
Public ClinicalTrials.gov record NCT03325010. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Dose Optimization Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2b, randomized, double-blind, placebo-controlled, dose-optimization study to evaluate the efficacy, safety, and tolerability of NBI-98854 titrated to the subject's optimal dose administered once daily (qd) for a total of 12 weeks of treatment in pediatric subjects with TS.
Study identification
- NCT ID
- NCT03325010
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 127 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 5, 2017 (Actual)
- Primary completion
- Nov 1, 2018 (Actual)
- Completion
- Nov 16, 2018 (Actual)
- Last update posted
- Jun 28, 2021
2017 – 2018
United States locations
- U.S. sites
- 34
- U.S. states
- 17
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Neurocrine Clinical Site | Sun City | Arizona | 85351 | — |
| Neurocrine Clinical Site | Rogers | Arkansas | 72758 | — |
| Neurocrine Clinical Site | Anaheim | California | 92805 | — |
| Neurocrine Clinical Site | San Diego | California | 92108 | — |
| Neurocrine Clinical Site | Santa Clarita | California | 91321 | — |
| Neurocrine Clinical Site | New Haven | Connecticut | 06519 | — |
| Neurocrine Clinical Site | Hialeah | Florida | 33012 | — |
| Neurocrine Clinical Site | Hialeah | Florida | 33013 | — |
| Neurocrine Clinical Site | Hialeah | Florida | 33018 | — |
| Neurocrine Clinical Site | Loxahatchee Groves | Florida | 33470 | — |
| Neurocrine Clinical Site | Orange City | Florida | 32763 | — |
| Neurocrine Clinical Site | Orlando | Florida | 32801 | — |
| Neurocrine Clinical Site | Orlando | Florida | 32803 | — |
| Neurocrine Clinical Site | Tampa | Florida | 33609 | — |
| Neurocrine Clinical Site | Chicago | Illinois | 60634 | — |
| Neurocrine Clinical Site | Chicago | Illinois | 60637 | — |
| Neurocrine Clinical Site | Naperville | Illinois | 60563 | — |
| Neurocrine Clinical Site | Iowa City | Iowa | 52242 | — |
| Neurocrine Clinical Site | Leawood | Kansas | 66206 | — |
| Neurocrine Clinical Site | Boston | Massachusetts | 02114 | — |
| Neurocrine Clinical Site | Lincoln | Nebraska | 68526 | — |
| Neurocrine Clinical Site | Nashua | New Hampshire | 03060 | — |
| Neurocrine Clinical Site | Mount Arlington | New Jersey | 07856 | — |
| Neurocrine Clinical Site | Voorhees Township | New Jersey | 08043 | — |
| Neurocrine Clinical Site | New York | New York | 10036 | — |
| Neurocrine Clinical Site | The Bronx | New York | 10467 | — |
| Neurocrine Clinical Site | Durham | North Carolina | 27705 | — |
| Neurocrine Clinical Site | Memphis | Tennessee | 38119 | — |
| Neurocrine Clinical Site | Dallas | Texas | 75243 | — |
| Neurocrine Clinical Site | Houston | Texas | 77058 | — |
| Neurocrine Clinical Site | Irving | Texas | 75062 | — |
| Neurocrine Clinical Site | Everett | Washington | 98201 | — |
| Neurocrine Clinical Site | Seattle | Washington | 98105 | — |
| Neurocrine Clinical Site | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03325010, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 28, 2021 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03325010 live on ClinicalTrials.gov.